Dr. Dempsey discusses how CDK4/6 Inhibitors have impacted medication costs for breast cancer care, and the importance of implementing cost containment strategies to alleviate the situation. Dr.

Results from the monarchE trial are analyzed by Hope Rugo, MD, and Joyce O'Shaughnessy, MD. Abemaciclib is recommended by NCCN in this setting based on the monarchE trial, which recently released its ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window At the San ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The ...

New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to pembrolizumab plus chemotherapy in early-stage triple-negative ...

Renowned breast oncologist and clinical researcher to lead ongoing efforts to accelerate diagnostic discoveries and enable precision oncology through real-world evidence-based study platform Dr.

Joyce O'Shaughnessy, MD, reflects on the important principle of patient autonomy and how, as a younger clinician, she encountered a patient with breast cancer who refused early intervention with ...

Joyce Purdy Cigna died peacefully on February 18, at age 92, after a short recurrence of a long-term illness. Predeceased by husband Jerome Paul Cigna and son Jerome Paul Cigna Jr. She is survived by ...